Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation

Heart Rhythm

Volumn 10, Issue 1, 2013, Pages 10-15

  Wu, Cheng Hsueh ^a,b   Hu, Yu Feng ^a,b   Chou, Chia Yu ^a,b   Lin, Yenn Jiang ^a,b   Chang, Shih Lin ^a,b   Lo, Li Wei ^a,b   Tuan, Ta Chuan ^a,b   Li, Cheng Hung ^a,b   Chao, Tze Fan ^a,b   Chung, Fa Po ^a,b   Liao, Jo Nan ^a   Chen, Shih Ann ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Atrial fibrillation; Atrial fibrosis; Catheter ablation; Transforming growth factor 1

Indexed keywords

AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVERSION; CATHETER ABLATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAROXYSMAL HEART ATRIUM FIBRILLATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY;

ATRIAL FIBRILLATION; CATHETER ABLATION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; ROC CURVE; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 84872019243     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.09.016     Document Type: Article

References (31)

1. P. Jais, B. Cauchemez, and L. Macle Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study Circulation 118 2008 2498 2505
2. B. Hartono, L.W. Lo, and C.C. Cheng A novel finding of the atrial substrate properties and long-term results of catheter ablation in chronic atrial fibrillation patients with left atrial spontaneous echo contrast J Cardiovasc Electrophysiol 23 2012 239 246
3. P. Sanders, M. Hocini, and P. Jais Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation. Long-term clinical outcome Eur Heart J 28 2007 1862 1871
4. F. Gramley, J. Lorenzen, E. Koellensperger, K. Kettering, C. Weiss, and T. Munzel Atrial fibrosis and atrial fibrillation: the role of the TGF-beta1 signaling pathway Int J Cardiol 143 2010 405 413
5. H. Xiao, H. Lei, S. Qin, K. Ma, and X. Wang TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease Clin Cardiol 33 2010 149 156
6. X. Li, C. Ma, and J. Dong The fibrosis and atrial fibrillation: is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation Med Hypotheses 70 2008 317 319
7. R. Khan, and R. Sheppard Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia Immunology 118 2006 10 24
8. S. Verheule, T. Sato, and T.T. Everett Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1 Circ Res 94 2004 1458 1465
9. Y.K. On, E.S. Jeon, and S.Y. Lee Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure J Thorac Cardiovasc Surg 137 2009 1515 1520
10. S.L. Chang, C.T. Tai, and Y.J. Lin Biatrial substrate properties in patients with atrial fibrillation J Cardiovasc Electrophysiol 18 2007 1134 1139
11. L.W. Lo, Y.J. Lin, and H.M. Tsao The impact of left atrial size on long-term outcome of catheter ablation of chronic atrial fibrillation J Cardiovasc Electrophysiol 20 2009 1211 1216
12. Y.J. Lin, C.T. Tai, and T. Kao Consistency of complex fractionated atrial electrograms during atrial fibrillation Heart Rhythm 5 2008 406 412
13. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
14. E.M. Balk, A.C. Garlitski, A.A. Alsheikh-Ali, T. Terasawa, M. Chung, and S. Ip Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review J Cardiovasc Electrophysiol 21 2010 1208 1216
15. S. Matsuo, N. Lellouche, and M. Wright Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation J Am Coll Cardiol 54 2009 788 795
16. T. Rostock, T.V. Salukhe, and D. Steven Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation Heart Rhythm 8 2011 1391 1397
17. Y. Takahashi, A. Takahashi, and T. Kuwahara Clinical characteristics of patients with persistent atrial fibrillation successfully treated by left atrial ablation Circ Arrhythm Electrophysiol 3 2010 465 471
18. A. Berruezo, D. Tamborero, and L. Mont Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation Eur Heart J 28 2007 836 841
19. M. Bhargava, L. Di Biase, and P. Mohanty Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study Heart Rhythm 6 2009 1403 1412
20. L.W. Lo, C.T. Tai, and Y.J. Lin Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: implications for catheter ablation strategy and long-term outcome Heart Rhythm 6 2009 311 318
21. A. Kourliouros, I. Savelieva, A. Kiotsekoglou, M. Jahangiri, and J. Camm Current concepts in the pathogenesis of atrial fibrillation Am Heart J 157 2009 243 252
22. S. Kostin, G. Klein, Z. Szalay, S. Hein, E.P. Bauer, and J. Schaper Structural correlate of atrial fibrillation in human patients Cardiovasc Res 54 2002 361 379
23. A. Boldt, U. Wetzel, and J. Lauschke Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease Heart 90 2004 400 405
24. B.L. Nguyen, M.C. Fishbein, L.S. Chen, P.S. Chen, and S. Masroor Histopathological substrate for chronic atrial fibrillation in humans Heart Rhythm 6 2009 454 460
25. A.Y. Tan, and P. Zimetbaum Atrial fibrillation and atrial fibrosis J Cardiovasc Pharmacol 57 2011 625 629
26. B. Burstein, and S. Nattel Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation J Am Coll Cardiol 51 2008 802 809
27. S.K. Kim, J.H. Park, and J.Y. Kim High plasma concentrations of transforming growth factor-beta and tissue inhibitor of metalloproteinase-1: potential non-invasive predictors for electroanatomical remodeling of atrium in patients with non-valvular atrial fibrillation Circ J 75 2011 557 564
28. M. Allessie, J. Ausma, and U. Schotten Electrical, contractile and structural remodeling during atrial fibrillation Cardiovasc Res 54 2002 230 246
29. H. Oral, B.P. Knight, and H. Tada Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation Circulation 105 2002 1077 1081
30. D. Katritsis, F.M. Merchant, T. Mela, J.P. Singh, E.K. Heist, and A.A. Armoundas Catheter ablation of atrial fibrillation the search for substrate-driven end points J Am Coll Cardiol 55 2010 2293 2298
31. H. Calkins, K.H. Kuck, and R. Cappato HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society Heart Rhythm 9 2012 632 696